258 related articles for article (PubMed ID: 26465118)
1. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
[TBL] [Abstract][Full Text] [Related]
2. NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.
Yotsumoto F; You WK; Cejudo-Martin P; Kucharova K; Sakimura K; Stallcup WB
Oncoimmunology; 2015 Apr; 4(4):e1001204. PubMed ID: 26137396
[TBL] [Abstract][Full Text] [Related]
3. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
[TBL] [Abstract][Full Text] [Related]
4. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
5. The NG2 Proteoglycan in Pericyte Biology.
Stallcup WB
Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
[TBL] [Abstract][Full Text] [Related]
6. NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair.
Kucharova K; Stallcup WB
J Neuroinflammation; 2015 Sep; 12():161. PubMed ID: 26338007
[TBL] [Abstract][Full Text] [Related]
7. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
Huang FJ; You WK; Bonaldo P; Seyfried TN; Pasquale EB; Stallcup WB
Dev Biol; 2010 Aug; 344(2):1035-46. PubMed ID: 20599895
[TBL] [Abstract][Full Text] [Related]
8. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
[TBL] [Abstract][Full Text] [Related]
9. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
[TBL] [Abstract][Full Text] [Related]
10. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
Ozerdem U
Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
[TBL] [Abstract][Full Text] [Related]
11. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
12. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
13. NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations.
Stallcup WB
Cancers (Basel); 2017 Mar; 9(4):. PubMed ID: 28362324
[TBL] [Abstract][Full Text] [Related]
14. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
Ozerdem U; Stallcup WB
Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
[TBL] [Abstract][Full Text] [Related]
15. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
16. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.
Wang J; Svendsen A; Kmiecik J; Immervoll H; Skaftnesmo KO; Planagumà J; Reed RK; Bjerkvig R; Miletic H; Enger PØ; Rygh CB; Chekenya M
PLoS One; 2011; 6(7):e23062. PubMed ID: 21829586
[TBL] [Abstract][Full Text] [Related]
18. NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin.
Chekenya M; Hjelstuen M; Enger PØ; Thorsen F; Jacob AL; Probst B; Haraldseth O; Pilkington G; Butt A; Levine JM; Bjerkvig R
FASEB J; 2002 Apr; 16(6):586-8. PubMed ID: 11919162
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
[TBL] [Abstract][Full Text] [Related]
20. Type-2 pericytes participate in normal and tumoral angiogenesis.
Birbrair A; Zhang T; Wang ZM; Messi ML; Olson JD; Mintz A; Delbono O
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C25-38. PubMed ID: 24788248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
